Literature DB >> 14968935

Mechanisms of hepatitis C virus infection.

Kohji Moriishi1, Yoshiharu Matsuura.   

Abstract

Hepatitis C virus (HCV) is the major causative agent of chronic non-A, non-B hepatitis. The life cycle of HCV is largely unknown because a reliable culture system has not yet been established. HCV presumably binds to specific receptor(s) and enters cells through endocytosis, as do other members of Flaviviridae. The viral genome is translated into a precursor polyprotein after uncoating, and viral RNA is synthesized by a virus-encoded polymerase complex. Progeny viral particles are released into the luminal side of the endoplasmic reticulum and secreted from the cell after passage through the Golgi apparatus. Understanding the mechanisms of HCV infection is essential to the development of effective new therapies for chronic HCV infection. Several host membrane proteins have been identified as receptor candidates for HCV. Recent advances using pseudotype virus systems have provided information surrounding the initial steps of HCV infection. An HCV RNA replicon system has been useful for elucidating the replication mechanism of HCV. In this review, we summarize our current understanding of the mechanisms of HCV infection and discuss potential antiviral strategies against HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14968935     DOI: 10.1177/095632020301400601

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  20 in total

1.  Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.

Authors:  Kousuke Nakai; Toru Okamoto; Tomomi Kimura-Someya; Koji Ishii; Chang Kweng Lim; Hideki Tani; Eiko Matsuo; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tatsuo Miyamura; Jack H Nunberg; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics.

Authors:  Michael R Defee; Zhiqiang Qin; Lu Dai; Jennifer S Isaacs; Chris H Parsons
Journal:  Am J Cancer Res       Date:  2011-06-05       Impact factor: 6.166

3.  Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.

Authors:  Junki Hirano; Toru Okamoto; Yukari Sugiyama; Tatsuya Suzuki; Shinji Kusakabe; Makoto Tokunaga; Takasuke Fukuhara; Miwa Sasai; Takahiro Tougan; Yasue Matsunaga; Kazuo Yamashita; Yusuke Sakai; Masahiro Yamamoto; Toshihiro Horii; Daron M Standley; Kohji Moriishi; Kyoji Moriya; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-29       Impact factor: 11.205

4.  Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

Authors:  Hiroto Kambara; Takasuke Fukuhara; Mai Shiokawa; Chikako Ono; Yuri Ohara; Wataru Kamitani; Yoshiharu Matsuura
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus.

Authors:  Shuhei Taguwa; Hiroto Kambara; Naonobu Fujita; Takeshi Noda; Tamotsu Yoshimori; Kazuhiko Koike; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

6.  CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan.

Authors:  Takayuki Abe; Takasuke Fukuhara; Xiauyu Wen; Akinori Ninomiya; Kohji Moriishi; Yoshihiko Maehara; Osamu Takeuchi; Taro Kawai; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

7.  Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation.

Authors:  Kiyoko Okamoto; Yoshio Mori; Yasumasa Komoda; Toru Okamoto; Masayasu Okochi; Masatoshi Takeda; Tetsuro Suzuki; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads.

Authors:  Jian Zhou; Yuancheng Huang; Deying Tian; Dong Xu; Miao Chen; Huiling Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

9.  A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication.

Authors:  Toru Okamoto; Hiroko Omori; Yuuki Kaname; Takayuki Abe; Yorihiro Nishimura; Tetsuro Suzuki; Tatsuo Miyamura; Tamotsu Yoshimori; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

10.  Human VAP-C negatively regulates hepatitis C virus propagation.

Authors:  Hiroshi Kukihara; Kohji Moriishi; Shuhei Taguwa; Hideki Tani; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Takasuke Fukuhara; Akinobu Taketomi; Yoshihiko Maehara; Yoshiharu Matsuura
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.